Introduction
Leishmaniasis represents a broad spectrum of diseases caused by obligate intracellular parasites belonging to the genus Leishmania . Leishmania infections are vector borne, spread by the bite of the female phlebotomine sandfly. Twenty species of Leishmania are pathogenic in human hosts, carried by 30 known species of sandflies. continents. In total 12 million people are infected with leishmaniasis, and 2 million new cases occur each year (1.5 million cutaneous and mucocutaneous, and 0.5 million visceral) [1] . Ninety percent of CL cases occur in Afghanistan, Brazil, Iran, Peru, Saudi Arabia and Syria, and 90% of ML cases occur in Bolivia, Brazil and Peru [2] . The majority of VL cases are found in poor areas of Bangladesh, India, Nepal, Sudan and Brazil [1] . It is officially estimated that 59,000 people die each year from VL [3] , but this number is probably a gross underestimate [1] .
Leishmaniasis represents a major global health problem. Cases of leishmaniasis continue to rise each year due to environmental risk factors such as migration, urbanization and deforestation, and individual risk factors such as malnutrition and immunosuppression. There has been a sharp increase in the number of VL cases worldwide due to HIV/ Leishmania coinfections. Currently there is no vaccine available, and the treatment regimens are less than ideal due to severe side effects, high costs and emerging resistance [1] . Therefore, further research that will lead to a better understanding of the immune responses involved in leishmaniasis is critically important for the development of future prevention and treatment strategies.
Immunology of Leishmaniasis
Leishmania species are capable of parasitizing cells of the mononuclear phagocyte lineage [4] , dendritic cells [5] and neutrophils [6] , although their definitive host cell is the tissue macrophage. Immunity against Leishmania is primarily mediated by T cells, and a substantial body of research exists to support a paradigm in which type 1 T helper cell (Th1) responses are associated with protective immunity and disease resolution, whereas type 2 T helper cell (Th2) responses are associated with susceptibility and disease exacerbation [7, 8] . Clinically, individuals who have successfully resolved infection exhibit strong delayed-type hypersensitivity (DTH) reactions, while individuals with nonhealing disease exhibit negative DTH reactions [4] .
During protective responses, IL-12 secretion by antigen-presenting cells and phagocytes stimulates naïve CD4+ T cells to differentiate into IFN-␥ -producing Th1 effector cells [8, 9] . This may occur independently or in conjunction with other cytokines such as IL-1 ␣ [10] , IL-18 [11] , IL-23 [12] and/or IL-27 [13] . In addition to its role in stimulating the adaptive immune response, IL-12 can also act on the innate immune system by inducing natural killer (NK) cells to secrete IFN-␥ early during infection [9] . Although NK cells do serve as early sources of IFN-␥ and may be involved in the initial development of Th1 responses, they are not required for ultimate disease resolution [14, 15] . IFN-␥ is critical in the protective response against leishmaniasis because it stimulates macrophage activation and the production of nitric oxide (NO) via expression of inducible NO synthase, enabling macrophages to effectively kill internalized parasites and infected hosts to resolve the disease [16, 17] . This leishmanicidal activity of IFN-␥ can be enhanced by TNF [18] and CD40/CD40L interactions [19] [20] [21] [22] .
In contrast, experimental animal models and individuals in whom Th2 responses predominate experience severe disease. Although it was initially thought that IL-4 was required for the development of Th2 responses and the differentiation of naïve CD4+ T cells into Th2 cells, further research has shown that IL-4 knockout mice are capable of mounting Th2 responses [23, 24] , and type 2 dendritic cells can induce the in vitro development of Th2 cells in the absence of IL-4 [25] , suggesting that IL-4 is not required for the initiation of Th2 responses and other mediators influence the development of Th2 responses [26] . In fact, IL-4 may be protective during visceral disease caused by Leishmania donovani [27, 28] and, under certain circumstances, is capable of directing Th1 responses [29] . While IL-4 may be capable of downregulating IFN-␥ production and macrophage activation during experimental disease [30, 31] , it appears that a failure to produce IL-12 and the inability to mount a Th1 response are more critical in determining disease susceptibility [26] . In addition to IL-4, other cytokines that have been shown to play a role in dampening Th1 leishmanicidal responses and driving disease progression and exacerbation include the Th2 cytokines IL-10 [32] , IL-13 [33] and the anti-inflammatory cytokine TGF-␤ [34] . Another factor that leads to disease exacerbation is antibody production. In experimental disease models, antibodies are not protective and actually mediate susceptibility to infection [35] . This corroborates the clinical finding that patients with nonhealing disease exhibit high antibody titers, while those who are healing or have cured disease have low antibody levels [36] .
sponses. Macrophages and lymphocytes, the two major cell types involved in the disease outcome of leishmaniasis, both possess receptors for sex hormones. Macrophages and T cells possess androgen [37] [38] [39] , estrogen [37, 40] and progesterone [41, 42] receptors. Based on these data, it is not surprising that gender can affect the outcome of various diseases, including leishmaniasis.
Evidence has indicated that both testosterone, the major circulating androgen in men, and progesterone, a hormone associated with the maintenance of pregnancy, are immunosuppressive. Both hormones reduce NK cell activity [43] [44] [45] [46] , impair macrophage production of TNF and NO [47] [48] [49] , and suppress NF B signal transduction, which is involved in mediating proinflammatory cytokine production [50] . Both hormones can also promote the production of Th2-associated anti-inflammatory cytokines such as IL-10 [47] and IL-4 [51] . Progesterone has been shown to act through the protein progesterone-induced blocking factor (PIBF). PIBF has been shown to activate STAT6, which positively regulates IL-4 production, while inhibiting STAT4, the transcription factor responsible for IL-12 production [52] . The anti-inflammatory properties of progesterone prevent the development of Th1 responses that could result in fetal abortion [42] .
In contrast to testosterone and progesterone, estrogen, or 17 ␤ -estradiol (E 2 ), is considered a proinflammatory mediator. Reports concerning the effect of E 2 on NK cells are conflicting. A study using human NK cells showed that E 2 enhances NK cell cytotoxicity [53] , while reports using murine NK cells found that E 2 reduces NK cell numbers [54] and inhibits NK cell cytotoxicity [55] . E 2 has been shown to stimulate the production of the proinflammatory cytokine TNF [56, 57] , is known to directly interact with the IFN-␥ promoter [58] , and has been shown to enhance antigen-specific CD4+ T cell responses [59] . The ability of E 2 to drive proinflammatory, Th1-associated immune responses and of testosterone to inhibit them may help to explain why females have a higher incidence of autoimmune disorders [60] and a lower incidence of parasitic infections [61] .
Sex Hormones and Leishmaniasis

Clinical Disease
As a general trend, males tend to be more susceptible to leishmaniasis than females, although there are exceptions. The vast majority of clinically based reports in the literature are epidemiological analyses or case studies that do not focus on the underlying mechanisms that render males more susceptible to infection. Nevertheless, the epidemiological analyses do indicate that most often males are more susceptible to CL, ML and VL.
A human study done in Campeche, Mexico, found that in a population of patients exhibiting Chiclero's ulcers caused by L. mexicana, only 10% of the infected population was female. The resistance of female subjects correlated with higher levels of GM-CSF [62] , which is a growth factor involved in macrophage and dendritic cell differentiation that has also been shown to improve CL treatments in conjunction with standard antimonial therapy [63] . Another human epidemiological study of a population in a deforested region of Colombia found that while gender was not a factor in acquiring infection with L. panamensis, males were at greater risk of developing more severe ML as a result of the infection [64] . As an exception to the general trend, one study in Kabul, Afghanistan, found that females were actually more susceptible to lesions and scars than men as a result of L. tropica infection [65] . This difference in results could represent genetic differences between the parasites responsible for New World (L. me xicana) and Old World (L. tropica) CL.
Both New World and Old World forms of VL show a strong association between gender and disease incidence and severity, with males being more likely to be infected and having more severe clinical presentations. A canine VL study in the endemic city of Split, Croatia, found that 19% of male dogs were seropositive for L. infatum, whereas only 9% of female dogs tested seropositive [66] . Studies of VL in humans have also exhibited a similar trend for L. chagasi infections in Brazil [67] and L. donovani infections in Somalia [68] . However, the report in Somalia and others attribute the higher prevalence of male infection to gender-associated differences in exposure and a higher proportion of male patients seeking medical care. While these factors probably do play a role in the gender differences seen in clinical cases, a great deal of experimental evidence suggests that modulation of infection by sex hormones is also relevant to the outcome of the disease.
Experimental Disease Models
Numerous reports have focused on studying the basis of gender differences exhibited in the immune responses of DBA/2 mice to CL. Interestingly, male and female DBA/2 mice exhibit different disease manifestations depending on the infective species. Following inoculation with L. major, both male and female DBA/2 mice form lesions. However, unlike the male counterparts, female mice do not resolve their lesions. In contrast, female DBA/2 mice infected with L. mexicana are highly resistant to disease and often do not exhibit lesions following high-dose inoculations, whereas male mice are highly susceptible and form chronic lesions upon low-dose infection [69] . This difference in experimental genderbased susceptibility mirrors the aforementioned clinical situation exhibited in humans suffering from Chiclero's ulcer due to L. mexicana in Mexico [62] versus L. tropica in Afghanistan [65] . The experimental difference is also most likely due to genetic differences between Leishmania species causing New World and Old World CL. Further research exploring the basis behind female DBA/2 resistance against L. mexicana has shown that female mice preferentially express and secrete more IFN-␥ during infection compared to male mice [70, 71] . This difference in IFN-␥ expression occurred despite the fact that there were no differences in the expression [70] or secretion [71] of IL-4 or IL-5 between male and female mice. However, female mice did exhibit a DTH response indicative of a Th1 response which was absent in males, and male mice exhibited high levels of Th2-associated IgG1 antibodies that were not detectable in female mice [71] . The importance of IFN-␥ in mediating resistance was confirmed by showing that treatment of female mice with neutralizing IFN-␥ antibodies resulted in lesion growth and progression equivalent to that of male mice [70] , and treatment of male mice with intralesional injections of IFN-␥ significantly inhibited lesion progression [71] . The resistance of female DBA/2 mice appears to be T cell dependent, as the transfer of immune female T cells into naïve male DBA/2 mice renders them highly resistant to infection ( fig. 1 ). Perhaps even more interesting is the fact that the transfer of naïve female T cells into male mice prior to infection confers significant (albeit reduced in comparison to the transfer of immune T cells) resistance ( fig. 1 ). To address whether male sex hormones could be involved in disease exacerbation, lesion size was compared in normal female mice, ovariectomized female mice, and ovariectomized female mice treated with 5 ␣ -dihydroxy testosterone (DHT) ( fig. 2 ) . While ovariectomizing female mice alone had little effect on lesion size, treatment of ovariectomized female mice with DHT significantly increased lesion size to levels comparable to those seen in male mice ( fig. 2 ) . These data suggest that male sex hormones can directly drive disease exacerbation. Although no published studies have been performed to date, studies on the effects of E 2 treatment on castrated male mice could provide insight into whether female sex hormones are capable of directly inhibiting lesion growth.
While the above studies implicate a role for sex hormones in the modulation of adaptive immunity against L. mexicana in DBA/2 mice, further studies were undertaken to determine whether sex hormones play a role in shaping innate immune responses. Using poly I:C as a stimulant it was found that male DBA/2 mice do not have an impairment in NK function ( fig. 3 ) . Bone marrow-derived macrophages (BMDMs) from female DBA/2 mice were found to be more resistant to in vitro L. mexicana infection than male BMDMs. E 2 treatment of both male and female BMDMs enhances parasite killing and NO production without an increase in the proinflammatory cytokine production of IL-6, IL-12 or TNF [74] . These data indicate that E 2 may enhance parasite killing by directly regulating NO production in DBA/2 mice. To determine if E 2 could enhance parasite killing on other murine genetic backgrounds, similar studies were performed on male and female BMDMs derived from C57BL/6 mice. It was found that E 2 was only capable of enhancing the leishmanicidal activity of female BMDMs and was as- sociated with higher levels of IFN-␥ R ␣ expression, IL-12, IL-6 and NO production. It was further shown that E 2 -treated BMDMs from PI3K ␥ knockout mice were less efficient in killing L. mexicana than E 2 -treated BMDMs from wild-type counterparts, despite producing similar levels of IL-6, IL-12, TNF and NO [75] . These data show that E 2 has differential effects on macrophage leishmanicidal activity between male and female C57BL/6 mice, and that while the PI3K ␥ pathway is not required for E 2 -induced proinflammatory cytokine and NO production in C57BL/6 macrophages, it may play a role in parasite clearance.
Other experimental disease models using C57BL/6 mice have studied the effect of pregnancy in the disease resolution of female mice infected with L. major . These studies sought to determine whether the tendency to mount Th2 responses during pregnancy could render normally resistant C57BL/6 female mice susceptible to disease with L. major . These studies found that when compared to nonpregnant infected mice, pregnant infected mice had higher parasite burdens associated with a reduction in IFN-␥ levels and increases in IL-4, IL-5 and IL-10 production [76] [77] [78] . These studies show that the predilection towards Th2 cell responses during pregnancy can impair normal Th1 responses against parasitic infections. However, whether progesterone, the primary hormone associated with pregnancy, is responsible for the downregulation of Th1 responses remains to be studied. Interestingly, another study on pregnancy showed that pregnant hamsters infected with cutaneous L. (Viannia) panamensis had lower parasite burdens associated with enhanced NO production by macrophages [79] . These disparate outcomes between disease models could be the result of differences in parasite and host genetics.
Another hamster study showed that male hamsters infected with L. (Viannia) panamensis were more susceptible to infection, exhibited larger and more severe lesions and had higher parasite burdens in draining lymph nodes -mexicana-infected female DBA/2 mice. Following general anesthesia, ovariectomy was performed as described previously [72] . Two weeks later, Silastic capsules containing 7 mg of DHT were implanted subcutaneously into the dorsal region just below the neck through small subcutaneous incisions (open squares). Control sham ovariectomized (closed diamonds) and intact (closed circles) female mice were similarly implanted with empty Silastic capsules. The incisions were closed using Michel Clips (7.5 ! 1.75 mm), and 2 weeks later the mice were infected with 5 ! 10 6 L. mexicana amastigotes subcutaneously into the shaven rump. All animals were individually ear marked, and disease progression was monitored in individual mice by measuring lesion diameter every 2 weeks up to week 10. Data are expressed as mean lesion diameter 8 standard error.
compared to females. More severe disease in males was associated with increases in Th2-associated IL-4 and IL-10, and anti-inflammatory TGF-␤ production [80] . In this disease model, the role of specific sex hormones in disease exacerbation/resistance needs to be further investigated. Male hamsters infected with L. donovani are also more susceptible to disease and have higher parasite burdens than the female counterparts. Treatment with exogenous testosterone enhanced disease in both male and female animals, while treatment with E 2 suppressed infection in both genders. Castration reduced parasite levels, while ovariectomy promoted disease [81] . This study demonstrates that male sex hormones are directly involved in disease exacerbation in VL in hamsters, while the female sex hormone E 2 mediates protection. Further in vitro studies have shown that testosterone treatment of L.-donovani-infected BMDMs results in an increase in initial parasite uptake [82] , and modulation of apoptosis. The precise role of testosterone in mediating apoptosis is unclear, as the literature presents conflicting reports in which one study demonstrates the inhibition of apoptosis via testosterone [83] and another reports increased apoptotic activity in cells treated with testosterone [84] .
Concluding Remarks
Our understanding of the role that sex hormones play in immunity against experimental Leishmania infections has dramatically increased over the past 10 years. Experimental models have shown that sex hormones can directly influence disease resistance or susceptibility. These studies have also shown that key immunological factors such as cytokines or NO can be differentially modulated as a result of gender or pregnancy. These experimental studies lay the foundation to better understand the variations exhibited during clinical disease. A better understanding of gender-dependent differences in human disease will allow for the design and development of more efficacious treatments and vaccination programs that will take gender differences into account.
